Unknown

Dataset Information

0

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer.


ABSTRACT: Background:Multidrug resistance (MDR) has been regarded as one of the major hurdles for the successful outcome of cancer chemotherapy. The collateral sensitivity (CS) effect is one the most auspicious anti-MDR strategies. Epoxylathyrane derivatives 1-16 were obtained by derivatization of the macrocyclic diterpene epoxyboetirane A (17), a lathyrane-type macrocyclic diterpene isolated from Euphorbia boetica. Some of these compounds were found to strongly modulate P-glycoprotein (P-gp/ABCB1) efflux. Purpose:The main goal was to develop lathyrane-type macrocyclic diterpenes with improved MDR-modifying activity, by targeting more than one anti-MDR mechanism. Study design/methods:In this study, the potential CS effect of compounds 1-16 was evaluated against gastric (EPG85-257), pancreatic (EPP85-181), and colon (HT-29) human cancer cells and their drug-resistant counterparts, respectively selected against mitoxantrone (EPG85-257RNOV; EPP85-181RNOV; HT-RNOV) or daunorubicin (EPG85-257RDB; EPP85-181RDB; HT-RDB). The most promising compounds (8, 15, and 16) were investigated as apoptosis inducers, using the assays annexin V/PI and active caspase-3. Results:The compounds were more effective against the resistant gastric cell lines, being the CS effect more significant in EPG85-257RDB cells. Taking together the IC50 values and the CS effect, compounds 8, 15, and 16 exhibited the best results. Epoxyboetirane P (8), with the strongest MDR-selective antiproliferative activity against gastric carcinoma EPG85-257RDB cells (IC50 of 0.72 µM), being 10-fold more active against this resistant subline than in sensitive gastric carcinoma cells. The CS effect elicited by compounds 15 and 16 appeared to be by inducing apoptosis via caspase-3 activation. Structure-activity relationships of the compounds were additionally obtained through regression models to clarify the structural determinants associated to the CS effect. Conclusions:This study reinforces the importance of lathyrane-type diterpenes as lead molecules for the research of MDR-modifying agents.

SUBMITTER: Reis MA 

PROVIDER: S-EPMC7226783 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer.

Reis Mariana Alves MA   Matos Ana M AM   Duarte Noélia N   Ahmed Omar Bauomy OB   Ferreira Ricardo J RJ   Lage Hermann H   Ferreira Maria-José U MU  

Frontiers in pharmacology 20200508


<h4>Background</h4>Multidrug resistance (MDR) has been regarded as one of the major hurdles for the successful outcome of cancer chemotherapy. The collateral sensitivity (CS) effect is one the most auspicious anti-MDR strategies. Epoxylathyrane derivatives <b>1-16</b> were obtained by derivatization of the macrocyclic diterpene epoxyboetirane A (<b>17</b>), a lathyrane-type macrocyclic diterpene isolated from <i>Euphorbia boetica</i>. Some of these compounds were found to strongly modulate P-gly  ...[more]

Similar Datasets

| S-EPMC7016283 | biostudies-literature
| S-EPMC9325490 | biostudies-literature
| S-EPMC5663620 | biostudies-literature
| S-EPMC4056062 | biostudies-literature
| S-EPMC3131311 | biostudies-literature
| S-EPMC3341370 | biostudies-literature
| S-EPMC9612322 | biostudies-literature
| S-EPMC9631746 | biostudies-literature
| S-EPMC9323234 | biostudies-literature
| S-EPMC5564821 | biostudies-other